12:00 AM
Mar 29, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Thalomid thalidomide: Began Pilot Testing

Celgene Corp. (CELG), Warren, N.J.
Product: Thalomid thalidomide
Business: Cancer
Therapeutic category: Angiogenesis
Target: Unknown
Description: Thalidomide...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >